SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Sick Visit — Vincent van Gogh
| Patient | Vincent van Gogh |
|---|
| Date of birth | 1990-03-30 |
|---|
| Identifiers | MRN HR-NI010-SYN; SSN (made up) 000-10-3198 |
|---|
| Document date | 2026-02-16 |
|---|
| Author | Elise Verhoeven, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Chief Complaint
Restlessness and inability to sit still for five days. [S]
History of Present Illness
Mr. van Gogh called the coordinated specialty care team and was seen the same day. Two weeks ago his aripiprazole was increased from 10 to 15 mg because he still heard his name called as he fell asleep. Since then the night-time voices have stopped, but for five days he has felt an inner restlessness he cannot switch off. He cannot sit at his easel for more than a few minutes, paces his studio, shifts his legs when sitting, and lies awake because his legs will not keep still. The feeling is worst in the late afternoon, a few hours after his morning dose. He was frightened that the illness was coming back, and the restlessness makes him irritable and miserable. He has had no confusion, no voices by day, and no stiffness or tremor. He has taken naltrexone daily, has had one or two drinks on three evenings this week, and has not drunk more to calm the feeling. He has not had thoughts of suicide or self-harm; the passive thoughts of not waking up have not returned. [S]
| Element | Detail |
|---|
| Onset | Five days ago, nine days after the aripiprazole increase to 15 mg |
| Location | Inner restlessness, mainly in the legs |
| Duration | Five days, constant |
| Character | An urge to move that he cannot resist; pacing; shifting his legs while sitting |
| Severity | Moderate; cannot paint or sleep through it |
| Timing | Worst in the late afternoon |
| Context | Aripiprazole increased from 10 to 15 mg two weeks ago |
| Modifying factors | Walking eases it briefly; coffee makes it worse |
| Associated signs and symptoms | Poor sleep and irritability; no voices by day, confusion, stiffness, tremor, fever, or thoughts of suicide or self-harm |
Review of Systems
| System | Result | Finding |
|---|
| Constitutional | Negative | No fever or sweats |
| Neurological | Positive | Restless legs and an urge to move; no stiffness, tremor, abnormal movements of the face or tongue, or weakness |
| Cardiovascular | Negative | No palpitations, fainting, or chest pain |
| Respiratory | Negative | No wheeze or asthma |
| Psychiatric | Positive | Anxious and irritable with the restlessness; poor sleep; no voices by day; no thoughts of suicide or self-harm |
5 systems reviewed. [S]
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Aripiprazole 10 mg oral tablet, one tablet by mouth once daily (started in hospital) | One tablet by mouth once daily | Oral route | 2026-01-05 to 2026-02-02 | completed | S |
| Aripiprazole 15 mg oral tablet, one tablet by mouth once daily | One tablet by mouth once daily | Oral route | 2026-02-02 to 2026-02-16 | completed | S |
| Naltrexone 50 mg oral tablet, one tablet by mouth once daily | One tablet by mouth once daily | Oral route | 2026-02-02 | active | S |
| Thiamine 100 mg oral tablet, one tablet by mouth daily (started in hospital) | One tablet by mouth daily | Oral route | 2026-01-05 to 2026-07-20 | completed | S |
| Aripiprazole 10 mg oral tablet, one tablet by mouth once daily | One tablet by mouth once daily | Oral route | 2026-02-16 | active | S |
| Propranolol 10 mg oral tablet, one tablet by mouth twice daily for akathisia | One tablet by mouth twice daily | Oral route | 2026-02-16 to 2026-03-02 | completed | S |
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Vital Signs
| Date | Measure | Value | Unit | Provenance |
| 2026-02-16 | Body height | 170 | cm | S |
| 2026-02-16 | Body weight | 64.4 | kg | S |
| 2026-02-16 | Body mass index (BMI) [Ratio] | 22.3 | kg/m2 | S |
| 2026-02-16 | Systolic blood pressure | 130 | mm[Hg] | S |
| 2026-02-16 | Diastolic blood pressure | 82 | mm[Hg] | S |
| 2026-02-16 | Heart rate | 96 | /min | S |
| 2026-02-16 | Respiratory rate | 16 | /min | S |
| 2026-02-16 | Body temperature | 36.7 | Cel | S |
| 2026-02-16 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
Physical Exam
Vital signs recorded on 2026-02-16; see the Vital Signs section. [S]
| System | Finding |
|---|
| General | Restless; stands and walks twice during the visit; blood pressure 130/82, pulse 96 |
| Neurological | Shifts his weight and crosses and uncrosses his legs while seated; Barnes global akathisia rating 3 (moderate); no rigidity, cogwheeling, tremor, or abnormal facial or tongue movements; gait normal |
| Cardiovascular | Regular rhythm; no murmur |
| Respiratory | Clear; no wheeze |
| Psychiatric | Distressed by the restlessness but organized and engaged; no hallucinations or delusions elicited |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| First episode of psychosis with mood features: weeks of very little sleep, intense work and expansive plans, then acute confusion, hallucinations and suspiciousness with self-injury, and low mood since discharge. Diagnosis provisional; differential: bipolar I disorder with psychotic features, brief psychotic or schizophreniform disorder, alcohol withdrawal delirium or alcohol-induced psychotic disorder, and psychosis related to focal epilepsy. Synthetic modern episode linked to his documented first crisis | active | provisional |
F29 | S — Synthetic modern coding of the documented first crisis. Unspecified psychosis is coded because the cause is not yet established; the retrospective diagnoses stay in the claims. |
| Alcohol use disorder, moderate (heavy daily wine and anise spirits before the episode); synthetic modern episode linked to his documented heavy drinking | active | confirmed |
F10.20 | S — Synthetic modern coding of the documented drinking and its retrospective interpretation. |
| Self-injury to the left ear during the acute confusional episode, without suicidal intent; wound healed after surgical care in hospital | active | confirmed |
Z91.52 | S — Synthetic modern coding of the documented injury; no detail of the injury is recorded. |
| Akathisia from aripiprazole, two weeks after the dose was increased to 15 mg; treated by returning to 10 mg and short-term propranolol; resolved | active | confirmed |
G25.71 | S — Synthetic medication side effect; not a historical claim. |
Assessment and Plan
- Akathisia from aripiprazole (G25.71). Moderate akathisia after the dose increase: subjective restlessness with observed movement, without parkinsonism or dyskinesia. It is not a return of the psychosis. Akathisia is distressing and is linked with impulsive behavior and suicidal thoughts, so it is treated promptly. Asthma and a slow pulse, which would prevent propranolol, are absent. A benzodiazepine is avoided because of his alcohol use. [S]
- Return aripiprazole to 10 mg daily from tomorrow.
- Propranolol 10 mg twice daily for a few weeks.
- Cut coffee to one cup in the morning.
- Phone check from the care coordinator in three days.
- First episode of psychosis, provisional diagnosis (F29). No voices since the increase; the lower dose may let them return, so he and the team will watch for them. Safety reviewed: no thoughts of suicide or self-harm; the safety plan and the 988 Suicide & Crisis Lifeline are in his phone, and he knows akathisia can make him feel desperate and to call if it does. [S]
- If night-time voices return on 10 mg, the team will review the dose at the six-week visit rather than raise it now.
- Six-week visit as planned.
- Alcohol use disorder on naltrexone (F10.20). One or two drinks on three evenings this week; he has not used alcohol to calm the restlessness. [S]
- Continue naltrexone and thiamine.
- No alcohol to treat the restlessness or to get to sleep.
Guideline basis: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition (2020); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024)
Follow-up: Care coordinator phone check in three days. Six-week visit in two weeks, or sooner if the restlessness does not ease within a week or if voices or dark thoughts return. Next scheduled visit 2026-03-02: six-week review: symptoms, side effects, alcohol, sleep, and test results. [S]